Orchid Chemicals & Pharmaceuticals has entered into an out-licensing and distribution agreement with the US-based pharma company Alvogen for marketing eight of Orchid's oral non-antibiotic generic formulations in the
Orchid will develop and manufacture eight oral non-antibiotic formulations for licensing to and marketing by Alvogen in the
Alvogen would pay certain dossier licence fees to Orchid based on development and regulatory milestones and share profits arising from marketing of these products in the
These formulations licensed to Alvogen under the agreement comprise products in the high-growth therapeutic segments of CNS and Osteoporosis among others. The combined addressable market size of these products is around $8 billion.
crackcrack| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: